Last update 08 May 2025

PPARγ x PRKAB1 x PPARα

Basic Info

Related Targets
PPARγPRKAB1PPARα

Related

1
Drugs associated with PPARγ x PRKAB1 x PPARα
Lobeglitazone Sulfate/Metformin Hydrochloride
Target
PPARα x PPARγ x PRKAB1
Mechanism
PPARα agonists [+2]
Active Org.-
Originator Org.
Chong Kun Dang Pharmaceutical Corp.Chong Kun Dang Pharmaceutical Corp.
Active Indication-
Inactive Indication
Diabetes Mellitus, Type 2
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
5
Clinical Trials associated with PPARγ x PRKAB1 x PPARα
NCT02685774
/ CompletedPhase 1
A Randomized, Open-label, Single Dose, 2-way Crossover Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500 mg in Healthy Male Volunteers
100 Clinical Results associated with PPARγ x PRKAB1 x PPARα
Login to view more data
100 Translational Medicine associated with PPARγ x PRKAB1 x PPARα
Login to view more data
0 Patents (Medical) associated with PPARγ x PRKAB1 x PPARα
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free